Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Equitable Acces and Adherence to Secondary Prevention Therapy With a Fixed-Dose Combination Drug

NCT01321255 is registered in ClinicalTrials.gov with Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III as lead sponsor.

NCT NCT01321255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01321255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Equitable Acces and Adherence to Secondary Prevention Therapy With a Fixed-Dose Combination Drug
Lead sponsor
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2014
Enrollment
2,118 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction